Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ADAM17 | P78536 | 20/20 | 0.46 |
| ▸ | ADAM10 | O14672 | 1/20 | 0.40 |
| ▸ | MMP1 | P03956 | 1/20 | 0.40 |
| ▸ | MMP2 | P08253 | 1/20 | 0.40 |
| ▸ | MMP3 | P08254 | 1/20 | 0.40 |
| ▸ | MMP9 | P14780 | 1/20 | 0.40 |
| ▸ | MMP13 | P45452 | 1/20 | 0.40 |
| ▸ | MMP14 | P50281 | 1/20 | 0.40 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL10200537 | 0.81 | ADAM17 (0.69) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7936501 | 0.75 | ADAM17 (0.69) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7935739 | 0.73 | ADAM17 (0.68) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7934550 | 0.73 | ADAM17 (0.67) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL10263769 | 0.70 | ADAM17 (0.69) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7945091 | 0.63 | ADAM17 (0.67) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7936482 | 0.63 | ADAM17 (0.81) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7934292 | 0.62 | ADAM17 (0.70) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7933919 | 0.62 | ADAM17 (0.69) | ADAM17ADAM10MMP1MMP2MMP3 | |
| SCHEMBL7934969 | 0.62 | ADAM17 (0.79) | ADAM17ADAM10MMP1MMP2MMP3 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2010054278-A2 | COMPOUNDS FOR THE TREATMENT OF INFLAMMATORY DISORDERS | SCHERING CORPORATION (US) | 2010-05-14 | — | — | WO | disclosed |